Dec 2012 : TATAA Biocenter announces to use and resell the new version of ePrime™
TATAA Biocenter announced a reseller agreement with Polyclone Bioservices to distribute ePrime™ – a qPCR primer & probe design application
click here for more...
Sep 2012 : Polyclone signs MoU with JSS University
Polyclone signs MoU with JSS University to expedite research and development of new methods and technologies that can be implemented
click here for more...
Sep 2012 : Application of nanotechnology in stem cell therapy
Mr. Naveen Kulkarni, CEO, Polyclone Bioservices, in discussion with Sachin Jagdale, reveals various scientific aspects of this research
click here for more...
Aug 2012 : Significance of enzyme engineering in life science industry
Mr. Naveen Kulkarni, CEO, Polyclone Bioservices, speaks about how the engineering of enzymes is leading to advances in the life science industry
click here for more...
Jul 2012 : Polyclone signs MoU with PSG Institute of Advanced Studies
Polyclone signs MoU with PSG Institute of Advanced Studies for cooperation in nanotechnology applications in stem cells
click here for more...
Feb 2012 : Polyclone co-hosts national conference
Polyclone co-organizes “National Conference on Biotechnological Prospecting in Herbal
Anti-viral & Anti-cancer drug development”
click here for more...
Oct 2011 : Market creation for sustainable business
Naveen Kulkarni, CEO of Polyclone
Bioservices, shares his experience and views on current challenges faced by Biotechnology
industry and ways to overcome them, in the cover story for BioSpectrum. click here for more...
Mar 2011 : Indian pharma industry must focus on becoming a powerhouse of
innovation
Polyclone Bioservices is an important
growth partner of many drug discovery companies. Sanjay Bettadpura, Chief Business
Officer, Polyclone Bioservices, opines on drug discovery scenario in India, in discussion
with Sachin Jagdale. click here
for more...
Nov 2010 : Biotech start-ups seek booster dose for growth
As risk capital flow for biotechnology
start-ups in India picks up, entrepreneurs are now seeking greater support in policy,
intellectual property management and growth facilities, find Sreekala G and Peerzada
Abrar.
click here for more...
Sep 2010 : First step towards a career in Biotech industry
Every year many aspiring graduates
come out of colleges seeking opportunities to work in the Biotechnology industry.
Shilpa Ramdurg, HR Manager, Polyclone Bioservices, provides some simple tips to
those 'freshers’ on how to make their way in the industry. click here for more...
Sep 2010 : Target Discovery - A Key Factor
Sanjay Bettadpura, CBO of Polyclone
Bioservices on the challenges faced by big pharma in target discovery & validation
and Polyclone's strategies to address them and emerge as the research partner of
choice in the field.
click here for more...
Nov 2009 : Polyclone presented at the Fourth Hanseatic India Colloquium,
Hamburg, Germany
Polyclone presented on the power
of Indo-German partnership for effective molecular assay design & validation.
click here for more...
Oct 2009 : Polyclone inks pact with Innovendia, Germany to increase presence
in EU
Polyclone Bioservices has entered
into an alliance with Innovendia Consulting of Germany. This will allow European
biotech-platform and drug discovery companies to have easier access to Polyclone’s
assay design and validation services. click here for more...
Apr 2009 : Polyclone Bioservices to focus on genotyping
Bangalore-based Polyclone Bioservices
has added genotyping into its arsenal of technologies and expertise. Polyclone would
focus on genotyping-based research in diagnostic and agricultural sectors and offer
services to both Indian and global customers.
click here for more...
Feb 2009 : New entrepreneurs and enterprises
Polyclone, which we featured
in 2006 as a new enterprise, has today grown into a complete genomics service provider
offering lab and computation based discovery, validation and analysis services to
biosuppliers, biotech platform and drug discovery companies. click here for more...
Sep 2007 : DSIR Recognition as an R&D company
Bangalore-based Polyclone Bioservices,
which provides services in genomics and drug discovery to the life sciences industry,
has made progressive strides in the last one year, the DSIR recognition as an R&D
company being the major highlight.
click here for more...
Apr 2007 : Polyclone, Eppendorf launch ePrime
India-based Polyclone Bioservices,
a company that develops and delivers scientific software applications and services
to biopharma, biotech and academic institutions, has launched its first product
ePrime. Polyclone will launch this in collaboration with Eppendorf. Eppendorf will
sell ePrime along with its PCR Equipment. click here for more...
Nov 2006 : Small Town Big Science
Drug discovery services is now
a well-established business in India. It all began with chemistry services in the
mid-1990s. Chemistry services are part of a later stage in drug discovery and include synthesis
of small molecule compounds to find out if they can become drugs. When
a pharma company discovers a potential drug, it usually seeks someone's help to
take this drug in enough quantities (pharma companies themselves would not like
to waste time on this activity). click here for more...
Nov 2006 : Silicon to fight Cancer
Polyclone Bioservices,
has developed a diagnostic tool based on microarray technology for detection of
cancer related diseases. A microarray, also known as a biochip, is collection of
microscopic genes on glass or a silicon chip. click here for more...
Oct 2006 : CEO Summit 2006
Naveen Kulkarni, CEO, Polyclone
Bioservices, outlining the essentials for a biotech entrepreneur, elaborated that
the road to success is not just research, but the ability to turn ideas into business;
create a flexible, yet efficient approach to building alliance portfolios; strategic
planning, identifying and accessing potential partners.